Merck: One Giant Leap…

From Stocks To Watch Today
January 11, 2017 - 10:28am

Last night, Merck (MRK) announced that not only had it filed for regulatory approval for its combination of Keytruda and chemotherapy but that the FDA had accepted the filing. The news caught the market by surprise, and has sent share of Merck soaring--they're up 4.6\% at $62.65 at 10:20 a.m. Bernstein's Tim Anderson explains why the announcement was such a big deal:

Continue reading this article »